Post-IPO Equity Life Science Companies

Forte Biosciences is a biotechnology company that focuses on dermatology.

Entheon is a addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule.

Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Hepion Pharmaceuticals is a clinical stage biopharmaceutical company.

Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.

GenFlow Biosciences is a biotech company that develops gene therapies for slow or reverse aging in humans and animals.

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.

Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Khiron is a medical cannabis company that promotes science, medicine, technology, innovation, and efficiency.

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Zura Bio is a clinical-stage, multi-asset biotechnology company.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

MYND Life Sciences is a life sciences company focused on novel psychedelic drug development and pharmaceuticals.

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,